0001013762-23-002839.txt : 20231010 0001013762-23-002839.hdr.sgml : 20231010 20231010161527 ACCESSION NUMBER: 0001013762-23-002839 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231010 FILED AS OF DATE: 20231010 DATE AS OF CHANGE: 20231010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PolyPid Ltd. CENTRAL INDEX KEY: 0001611842 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38428 FILM NUMBER: 231318152 BUSINESS ADDRESS: STREET 1: 18 HASIVIM STREET CITY: PETACH TIKVA STATE: L3 ZIP: 495376 BUSINESS PHONE: 972-74-7195700 MAIL ADDRESS: STREET 1: 18 HASIVIM STREET CITY: PETACH TIKVA STATE: L3 ZIP: 495376 6-K 1 ea186499-6k_polypid.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of: October 2023 (Report No. 2)

 

Commission File Number: 001-38428

 

PolyPid Ltd.

(Translation of registrant’s name into English)

 

18 Hasivim Street

Petach Tikva 495376, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

☒ Form 20-F ☐ Form 40-F

 

 

 

 

CONTENTS

 

On October 9, 2023, PolyPid Ltd. (the “Company”) convened an Extraordinary General Meeting of Shareholders (the “Meeting”).

 

The Meeting was called for the following proposals: 

Proposal No. 1

To approve compensation to Mr. Yossi BenAmram, one of the Company’s directors; and 

   
Proposal No. 2 To approve a grant of options to the Company’s Chief Executive Officer, Ms. Dikla Czaczkes Akselbrad.

 

At the Meeting, a quorum was present, and the shareholders of the Company approved Proposal No. 1 and Proposal No. 2.

 

The Report on Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (File No. 333-257651) and Form S-8 (File No. 333-239517 and File No. 333-271060), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  POLYPID LTD.
     
Date: October 10, 2023 By: /s/ Dikla Czaczkes Akselbrad
    Name: Dikla Czaczkes Akselbrad
    Title: Chief Executive Officer

 

2